HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ADIDAC trial: analgesia with dexibuprofen versus ibuprofen in patients suffering from primary dysmenorrhea: a crossover trial.

AbstractBACKGROUND:
Primary dysmenorrhea is estimated to affect 40-50% of menstruating young women.
METHODS:
Randomized, double-blind, 3-cycle crossover, active-controlled clinical trial conducted in 102 outpatients.
RESULTS:
102 patients entered the study and 77 were eligible for analyses. The mean (SD) age was 31.1 (7.0) years, and the mean cycle duration was 28.1 days (1.89) with a mean menstrual phase of 5.3 days (1.28). 40.26% of patients reported moderate pain from dysmenorrhea, and the remaining 59.74% reported severe pain. Compared to ibuprofen 400 mg, both dexibuprofen doses (200 and 300 mg) showed a trend towards superiority for sum of pain intensity difference (sum of PID), PID and total pain relief. Furthermore, dexibuprofen 200 mg had a faster onset of action compared to the double dose of ibuprofen (p = 0.035). A dose-effect relationship could be demonstrated for dexibuprofen in this visceral pain model. Tolerability was similar across all treatments.
CONCLUSIONS:
In patients experiencing acute visceral pain as a result of primary dysmenorrhea, dexibuprofen was associated with a dose-dependent effective analgesia; this effect was at least equivalent to that of the double dose of ibuprofen. With its lower body-loading dose, dexibuprofen expands the alternatives available to treat this condition.
AuthorsC Kollenz, W Phleps, S T Kaehler
JournalGynecologic and obstetric investigation (Gynecol Obstet Invest) Vol. 67 Issue 1 Pg. 25-31 ( 2009) ISSN: 1423-002X [Electronic] Switzerland
PMID18824862 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Ibuprofen
Topics
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage)
  • Cross-Over Studies
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Dysmenorrhea (drug therapy, pathology)
  • Female
  • Humans
  • Ibuprofen (administration & dosage)
  • Pain (prevention & control)
  • Statistics, Nonparametric
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: